The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...

Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

Instead of creating affordable products that improve health and lower costs, pharmaceutical companies focus on new drugs that will yield a healthy return on investment.

The growing strength of China’s drug pipelines has gone hand-in-hand with a steep uptick in big pharma licensing deals.

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

FDA consumer safety officer discussed the challenges of navigating policy and politics in rare diseases at a recent meeting.

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

They've identified which grants wouldn't have been funded had similar cuts been made earlier in this century and tracked the ...

Herriot Tabuteau combined his Yale medical degree and two decades in finance to start Axsome Therapeutics. Now the company ...